Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Present standards for cervical cancer screening.

Anne T O'Meara1

  • 1Keck School of Medicine, University of California, Los Angeles 90033, USA. aomeara@usc.edu

Current Opinion in Oncology
|August 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant melanoma in pregnancy. A population-based evaluation.

Cancer·2005
Same author

Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience.

Gynecologic oncology·2004
Same author

Uterine sarcomas: have we made any progress?

Current opinion in obstetrics & gynecology·2004
Same author

The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.

Gynecologic oncology·2003
Same author

Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma.

Gynecologic oncology·2003
Same author

Pancreatic cancer: evidence-based diagnosis and treatment.

Clinical obstetrics and gynecology·2002
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Cervical cancer screening has improved survival rates, with new technologies like HPV testing and thin-layer Pap smears showing promise for early detection of cervical dysplasia. Guidelines now incorporate HPV testing for managing abnormal results.

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Background:

  • Cervical cancer survival rates have significantly improved due to screening measures like the Pap smear.
  • Early detection and treatment of preinvasive cervical dysplasia are crucial for reducing invasive cervical cancer incidence.

Purpose of the Study:

  • To review advancements in cervical cancer screening, including new technologies and updated guidelines.
  • To evaluate the efficacy of human papilloma virus (HPV) testing and thin-layer Pap smear technology.

Main Methods:

  • Review of published studies on new Pap smear technologies (thin-layer, automated rescreening).
  • Analysis of current recommendations for screening intervals and HPV testing integration.
  • Examination of new guidelines for reporting (Bethesda System) and managing abnormal Pap smears (ASCCP).

Related Experiment Videos

Main Results:

  • Thin-layer Pap smear technology may enhance sensitivity for detecting cervical dysplasia.
  • Automated rescreening offers a potential method to reduce false-negative Pap smears.
  • New guidelines incorporate HPV testing for triage of atypical squamous cells, supported by multicenter trials.

Conclusions:

  • While more data is needed to confirm improved outcomes from new technologies, current evidence is promising.
  • Updated guidelines and the integration of HPV testing represent significant advancements in cervical cancer screening protocols.